ctrl K

Watchlist Price Alert

Keros Therapeutics Inc. (KROS)

NASDAQ: KROS · Real-Time Price · USD

13.48

-0.18 (-1.32%)

At close: Jun 17, 2025, 3:59 PM

13.46

-0.15%

After-hours: Jun 17, 2025, 04:20 PM EDT

Keros Therapeutics Revenue Breakdown

Period Ending	Dec 31, 2024	Dec 31, 2022	Dec 31, 2021
Service Revenue	3M	144M	144M
Service Revenue Growth	-97.92%	0.00%	n/a
License Revenue	144M	n/a	n/a
License Revenue Growth	n/a	n/a	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	10.5M	10.66M	9.82M	9.65M	10.31M	9.11M	9.15M	8.8M	7.78M	7.09M	6.94M	7.45M	6.05M	6.03M	5.37M	5.66M	4.27M	3.62M	3.55M	3.65M	1.98M	1.07M	972K	654K	491K
Selling, General, and Administrative Revenue Growth	-1.58%	+8.60%	+1.71%	-6.33%	+13.21%	-0.47%	+3.92%	+13.18%	+9.66%	+2.25%	-6.85%	+23.13%	+0.25%	+12.45%	-5.18%	+32.38%	+18.16%	+1.80%	-2.66%	+84.62%	+85.29%	+9.77%	+48.62%	+33.20%	n/a
Research and Development Revenue	48.71M	45.63M	49.23M	40.52M	38.26M	37.49M	34.14M	32.53M	31.09M	24.87M	21.04M	23.28M	18.08M	18.83M	14.83M	9.98M	11.49M	9.67M	8.39M	7.26M	8.53M	4.16M	3.85M	4.5M	4.87M
Research and Development Revenue Growth	+6.75%	-7.30%	+21.50%	+5.90%	+2.04%	+9.82%	+4.94%	+4.64%	+25.03%	+18.19%	-9.63%	+28.78%	-4.01%	+26.98%	+48.57%	-13.15%	+18.82%	+15.24%	+15.57%	-14.81%	+104.93%	+7.97%	-14.30%	-7.60%	n/a